Rethinking C-reactive protein Steve EdelsonGaspar Taroncher-Oldenburg BriefCommunication Pages: 1063 - 1063
IL-17; IL-6; interferon-γ (IFN-γ); signal transducer and activator of transcription 3 (STAT3) BriefCommunication Pages: 1069 - 1069
Mitogen-activated protein kinase kinase kinase kinase 3 (MAP4K3) BriefCommunication Pages: 1070 - 1070
Kallikrein-related peptidase 4 (KLK4); protease-activated receptor 1 (PAR1); PAR2 BriefCommunication Pages: 1075 - 1075
Ewing's sarcoma breakpoint region 1 (EWSR1; EWS-Fli1); DEAH (Asp-Glu-Ala-His) box polypeptide 9 (DHX9; RHA) BriefCommunication Pages: 1076 - 1076
Candida albicans zinc-regulated transcription factor (Zap1); C. albicans glucoamylase 1 (Gca1); Gca2; C. albicans alcohol-keto reductase (Csh1); C. albicans alcohol dehydrogenase (Sad1; Adh5; CaO19.2608) BriefCommunication Pages: 1080 - 1080
Plasmodium falciparum hypoxanthine phosphoribosyltransferase 1 (Hprt1; Hgprt) BriefCommunication Pages: 1082 - 1082
West Nile virus non-structural protein 3 protease (WNV NS3); West Nile virus non-structural cofactor 2B (WNV NS2B) BriefCommunication Pages: 1083 - 1083
Benzodiazepine receptor (peripheral)-associated protein 1 (BZRAP1); MAM domain containing glycosylphosphatidylinositol anchor 2 (MDGA2); contactin 4 (CNTN4); neurexin 1 (NRXN1) BriefCommunication Pages: 1087 - 1087
Dystrophia myotonica protein kinase (DMPK); ataxin 3 (ATXN3); muscleblind-like 1 (MBNL1) BriefCommunication Pages: 1090 - 1090
High throughput screening platform for identifying synergistic drug combinations BriefCommunication Pages: 1091 - 1091
Computer-based tool for identifying biologically active chemical scaffolds in silico (Scaffold Hunter) BriefCommunication Pages: 1093 - 1093
Mouse model for paired box gene 6 (PAX6)-associated neurological and memory deficits BriefCommunication Pages: 1094 - 1094
Phloretin-adjustable control element (PEACE) to regulate transgene expression BriefCommunication Pages: 1095 - 1095
A radiolabeled P glycoprotein (ABCB1; MDR; P-gp) substrate for monitoring treatment of neurological diseases BriefCommunication Pages: 1096 - 1096